ML-14 LOW INVASIVE APPROACH FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT INVOLVING RITUXIMAB–METHOTREXATE + PROCARBAZINE + VINCRISTINE AND TRIPLE INTRATHECAL INJECTION

INTRODUCTION: Although the treatment outcomes of primary central nervous system lymphoma (PCNSL) with multiple treatment regimens involving high–dose methotrexate (MTX)–based multiagent chemotherapy have improved compared with the outcomes with high–dose methotrexate therapy in recent years, its reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Takahiro, Oowada, Kei, Tanba, Kazuna, Hirakawa, Kouichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213455/
http://dx.doi.org/10.1093/noajnl/vdz039.156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213455/
http://dx.doi.org/10.1093/noajnl/vdz039.156

Ejemplares similares